EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:EBM - CA27783W1059 - Common Stock
EBM.CA Key Statistics, Chart & Performance
The current stock price of EBM.CA is 0.81 CAD. In the past month the price increased by 9.46%. In the past year, price increased by 63.64%.
EBM.CA Competitors/Peers
Related stock screener links
About EBM.CA
Company Profile
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The firm's Eleotin products include natural remedies for certain metabolic disorders, such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products which have Health Canada product license numbers include Eleotin A 700, Eleotin AL88, Eleotin Cal20, Eleotin V3D, Eleotin G2000, Eleotin H55, and Eleotin Zn330. Additionally, Eleotin Bentley and Eleotin LBM have received Health Canada product license numbers. Eleotin Bentley is used to promote healthy glucose levels while Eleotin LBM is recommended for hypertension relief. The company manufactures and allocates resources towards the research and development of products.
Company Info
EASTWOOD BIO-MEDICAL CANADA
1130 - 4871 Shell Road
RICHMOND BRITISH COLUMBIA V6X 3Z6 CA
CEO: Yunji Kim
Employees: 1
Phone: 16042472100
EASTWOOD BIO-MEDICAL CANADA / EBM.CA FAQ
What does EASTWOOD BIO-MEDICAL CANADA do?
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The firm's Eleotin products include natural remedies for certain metabolic disorders, such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products which have Health Canada product license numbers include Eleotin A 700, Eleotin AL88, Eleotin Cal20, Eleotin V3D, Eleotin G2000, Eleotin H55, and Eleotin Zn330. Additionally, Eleotin Bentley and Eleotin LBM have received Health Canada product license numbers. Eleotin Bentley is used to promote healthy glucose levels while Eleotin LBM is recommended for hypertension relief. The company manufactures and allocates resources towards the research and development of products.
What is the stock price of EASTWOOD BIO-MEDICAL CANADA today?
The current stock price of EBM.CA is 0.81 CAD.
What is the dividend status of EASTWOOD BIO-MEDICAL CANADA?
EBM.CA does not pay a dividend.
How is the ChartMill rating for EASTWOOD BIO-MEDICAL CANADA?
EBM.CA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of EASTWOOD BIO-MEDICAL CANADA (EBM.CA) based on its PE ratio?
EASTWOOD BIO-MEDICAL CANADA (EBM.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
EBM.CA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to EBM.CA. When comparing the yearly performance of all stocks, EBM.CA is one of the better performing stocks in the market, outperforming 86.52% of all stocks.
EBM.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EBM.CA. EBM.CA may be in some trouble as it scores bad on both profitability and health.
EBM.CA Financial Highlights
Over the last trailing twelve months EBM.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 15.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -189.94% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |